These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 24522986)

  • 1. The promise of modern radiotherapy in resected pancreatic adenocarcinoma: a response to Bekaii-Saab et al.
    Narang AK; Herman JM
    Ann Surg Oncol; 2014 Apr; 21(4):1064-6. PubMed ID: 24522986
    [No Abstract]   [Full Text] [Related]  

  • 2. The addition of radiation to chemotherapy does not improve outcome when compared to chemotherapy in the treatment of resected pancreas cancer: the results of a single-institution experience.
    Martin LK; Luu DC; Li X; Muscarella P; Ellison EC; Bloomston M; Bekaii-Saab T
    Ann Surg Oncol; 2014 Mar; 21(3):862-867. PubMed ID: 24046122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant therapy for gastric cancers: more answers or more questions?
    Hong TS; Kwak EL
    Ann Surg Oncol; 2014 Oct; 21(11):3367-8. PubMed ID: 24841350
    [No Abstract]   [Full Text] [Related]  

  • 4. Pancreatic adenocarcinoma: treating a systemic disease with systemic therapy.
    Sohal DP; Walsh RM; Ramanathan RK; Khorana AA
    J Natl Cancer Inst; 2014 Mar; 106(3):dju011. PubMed ID: 24563516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma.
    Saidi RF; Jacobs MJ
    Ann Surg; 2009 May; 249(5):865; author reply 865-6. PubMed ID: 19387303
    [No Abstract]   [Full Text] [Related]  

  • 6. Pancreatic adenocarcinoma: Clinical Practice Guidelines in Oncology.
    Tempero MA; Behrman S; Ben-Josef E; Benson AB; Cameron JL; Casper ES; Hoffman JP; Karl RC; Kim P; Koh WJ; Kuvshinoff BW; Melvin WS; Muscarella P; Sasson AR; Shibata S; Shrieve DC; Talamonti MS; Tyler DS; Vickers SM; Warren RS; Willett C; Wolff RA;
    J Natl Compr Canc Netw; 2005 Sep; 3(5):598-626. PubMed ID: 16194453
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study.
    Labori KJ; Katz MH; Tzeng CW; Bjørnbeth BA; Cvancarova M; Edwin B; Kure EH; Eide TJ; Dueland S; Buanes T; Gladhaug IP
    Acta Oncol; 2016; 55(3):265-77. PubMed ID: 26213211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational study endpoint(s) for preoperative trials in pancreatic cancer: pathologic response rate, margin negative resection, overall survival or 'all of the above'?
    Varadhachary GR; Evans DB
    Ann Surg Oncol; 2013 Nov; 20(12):3712-4. PubMed ID: 23943023
    [No Abstract]   [Full Text] [Related]  

  • 9. Addition of radiotherapy to adjuvant chemotherapy is associated with improved overall survival in resected pancreatic adenocarcinoma: An analysis of the National Cancer Data Base.
    Rutter CE; Park HS; Corso CD; Lester-Coll NH; Mancini BR; Yeboa DN; Johung KL
    Cancer; 2015 Dec; 121(23):4141-9. PubMed ID: 26280559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of neoadjuvant therapy on local recurrence after resection of pancreatic adenocarcinoma.
    Greer SE; Pipas JM; Sutton JE; Zaki BI; Tsapakos M; Colacchio TA; Gibson JJ; Wiener DC; Ripple GH; Barth RJ
    J Am Coll Surg; 2008 Mar; 206(3):451-7. PubMed ID: 18308215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant therapy of pancreatic cancer.
    Hilbig A; Oettle H
    Expert Rev Anticancer Ther; 2010 Apr; 10(4):485-91. PubMed ID: 20397913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adenocarcinoma of the pancreas. Therapeutic strategies].
    André T; Balosso J; Louvet C; Houry S; Vaillant JC; Touboul E; Lotz JP; de Gramont A; Izrael V
    Presse Med; 1998 Mar; 27(11):539-45. PubMed ID: 9767970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemoradiotherapy including intraoperative radiotherapy for advanced and relapsed pancreatic tumors].
    Matsumoto G; Tsuruta K; Okamoto A; Karasawa K; Kamata N
    Nihon Rinsho; 2006 Jan; 64 Suppl 1():243-7. PubMed ID: 16457259
    [No Abstract]   [Full Text] [Related]  

  • 14. Adjuvant therapy for pancreatic cancer: to treat or not to treat?
    Berlin JD
    Oncology (Williston Park); 2007 May; 21(6):712-8; discussion 720, 725-6, 730. PubMed ID: 17564327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does prior adjuvant chemoradiotherapy lead to a safer pancreatoduodenectomy?
    Hoffman J
    Ann Surg Oncol; 2006 Jan; 13(1):7-9. PubMed ID: 16372149
    [No Abstract]   [Full Text] [Related]  

  • 16. Adjuvant bi-weekly combination of cisplatin, infusional 5-fluorouracil and folinic acid followed by concomitant chemoradiotherapy with infusional fluorouracil for high risk operated gastric and gastroesophageal junction adenocarcinoma.
    Uncu D; Ozdemir NY; Aksoy S; Abali H; Oksuzoglu BC; Budakoglu B; Yildiz R; Aslan N; Zengin N
    Asian Pac J Cancer Prev; 2010; 11(6):1493-7. PubMed ID: 21338186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II study of adjuvant S-1/cisplatin chemotherapy followed by S-1-based chemoradiotherapy for D2-resected gastric cancer.
    Shim HJ; Kim KR; Hwang JE; Bae WK; Ryu SY; Park YK; Nam TK; Chung IJ; Cho SH
    Cancer Chemother Pharmacol; 2016 Mar; 77(3):605-12. PubMed ID: 26846507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
    Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
    Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of external-beam radiation therapy on outcomes among patients with resected gastric cancer: a multi-institutional analysis.
    Ejaz A; Spolverato G; Kim Y; Squires MH; Poultsides G; Fields R; Bloomston M; Weber SM; Votanopoulos K; Worhunsky DJ; Swords D; Jin LX; Schmidt C; Acher AW; Saunders N; Cho CS; Herman JM; Maithel SK; Pawlik TM
    Ann Surg Oncol; 2014 Oct; 21(11):3412-21. PubMed ID: 24845728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should the Optimal Adjuvant Treatment for Patients With Early-Stage Endometrial Cancer With High-Intermediate Risk Factors Depend on Tumor Grade?
    Lan C; Huang X; Huang Q; Wang Y; Gu H; Li Y; Liu J
    Int J Gynecol Cancer; 2015 Oct; 25(8):1445-52. PubMed ID: 26397067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.